[DPHARMA] YoY Cumulative Quarter Result on 30-Jun-2014 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- 89.98%
YoY- -8.6%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Revenue 240,355 158,605 101,907 81,118 75,826 70,412 68,329 23.29%
PBT 24,764 17,664 20,605 21,302 21,963 17,906 17,166 6.29%
Tax -5,559 -5,895 -5,788 -5,410 -4,575 -4,331 -4,310 4.32%
NP 19,205 11,769 14,817 15,892 17,388 13,575 12,856 6.91%
-
NP to SH 19,217 12,346 14,817 15,892 17,388 13,575 12,856 6.92%
-
Tax Rate 22.45% 33.37% 28.09% 25.40% 20.83% 24.19% 25.11% -
Total Cost 221,150 146,836 87,090 65,226 58,438 56,837 55,473 25.89%
-
Net Worth 463,071 446,334 190,284 179,045 187,340 162,400 154,105 20.10%
Dividend
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Div 6,973 6,973 5,596 5,551 5,550 4,858 4,859 6.19%
Div Payout % 36.29% 56.49% 37.77% 34.93% 31.92% 35.79% 37.80% -
Equity
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Net Worth 463,071 446,334 190,284 179,045 187,340 162,400 154,105 20.10%
NOSH 278,959 278,959 139,915 138,794 138,770 138,803 138,833 12.32%
Ratio Analysis
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
NP Margin 7.99% 7.42% 14.54% 19.59% 22.93% 19.28% 18.81% -
ROE 4.15% 2.77% 7.79% 8.88% 9.28% 8.36% 8.34% -
Per Share
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 86.16 56.86 72.83 58.44 54.64 50.73 49.22 9.77%
EPS 6.88 4.22 10.59 11.45 12.53 9.78 9.26 -4.82%
DPS 2.50 2.50 4.00 4.00 4.00 3.50 3.50 -5.44%
NAPS 1.66 1.60 1.36 1.29 1.35 1.17 1.11 6.93%
Adjusted Per Share Value based on latest NOSH - 138,872
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 24.99 16.49 10.59 8.43 7.88 7.32 7.10 23.31%
EPS 2.00 1.28 1.54 1.65 1.81 1.41 1.34 6.89%
DPS 0.72 0.72 0.58 0.58 0.58 0.51 0.51 5.91%
NAPS 0.4814 0.464 0.1978 0.1861 0.1948 0.1688 0.1602 20.10%
Price Multiplier on Financial Quarter End Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 -
Price 2.25 2.04 2.65 2.97 2.38 2.23 2.34 -
P/RPS 2.61 3.59 3.64 5.08 4.36 4.40 4.75 -9.48%
P/EPS 32.66 46.09 25.02 25.94 18.99 22.80 25.27 4.36%
EY 3.06 2.17 4.00 3.86 5.26 4.39 3.96 -4.20%
DY 1.11 1.23 1.51 1.35 1.68 1.57 1.50 -4.89%
P/NAPS 1.36 1.28 1.95 2.30 1.76 1.91 2.11 -7.05%
Price Multiplier on Announcement Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 25/08/17 22/08/16 25/08/15 26/08/14 28/08/13 16/08/12 18/08/11 -
Price 2.03 2.14 2.40 3.37 2.44 2.38 2.22 -
P/RPS 2.36 3.76 3.30 5.77 4.47 4.69 4.51 -10.22%
P/EPS 29.47 48.35 22.66 29.43 19.47 24.34 23.97 3.49%
EY 3.39 2.07 4.41 3.40 5.14 4.11 4.17 -3.38%
DY 1.23 1.17 1.67 1.19 1.64 1.47 1.58 -4.08%
P/NAPS 1.22 1.34 1.76 2.61 1.81 2.03 2.00 -7.90%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment